Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Maynard Ryan D
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
View:
Company
Cara Therapeutics, Inc.
Iovance Biotherapeutics, Inc.
Rigel Pharmaceuticals, Inc.
Rigel Pharmaceuticals, Inc.
EVP & CFO
Avg. Two Year Performance
No Purchase Track Record
67%
Avg. Sale Return
29%
Compound
Holdings: 0 shares
Last Three Months: 23-Aug-24 -- 22-Nov-24
0
Net Amount
Buy:
0
--
Sell:
0
--
Sentiment
Company Sentiment
Drug Manufacturers - Major
Drugs
Two Year Chart
23-Nov-22 -- 22-Nov-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions
